measurement

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 55/100

   Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays

   ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Journal of neurochemistry · 2025-07-01 · Biomarkers

   Phosphorylated tau (p-tau) 217 is a promising blood biomarker for Alzheimer's disease (AD).

   • Biomarkers
2. 67/100

   Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 67 out of 100. Journal of neuroinflammation · 2023-12-13 · Biomarkers

   Cross-sectionally, CSF sTREM2, YKL-40, clusterin and fractalkine were higher only in groups with tau pathology, independent of amyloidosis (p < 0.001, A+/T+ or N+ and A-/T+ or N+, compared to A-/T-/N-).

   • Biomarkers
3. 45/100

   An Ensemble Method for Diagnosis of Parkinson's Disease Based on Voice Measurements

   ✓ Peer-reviewed alzhub usefulness score 45 out of 100. Journal of medical signals and sensors · 2019-10-24 · Biomarkers

   Current experimental outcomes provide a comparative analysis of various machine learning classifiers and confirm that using ensemble-based methods has improved medical diagnostic tasks.

   • Diagnosis
   • Other Dementias
4. 41/100

   Towards a unified protocol for handling of CSF before β-amyloid measurements

   ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Alzheimer's research & therapy · 2019-07-19 · Biomarkers

   CSF can be stored for up to 72 h at RT, 1 week at 4 °C, or at least 2 weeks at either - 20 °C or - 80 °C before Aβ measurements.

   • Biomarkers
5. 64/100

   Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease

   ✓ Peer-reviewed alzhub usefulness score 64 out of 100. Alzheimer's research & therapy · 2019-02-20 · Biomarkers

   There is evidence that serum NfL is increased more than a decade before the onset of clinical symptoms in FAD and rises thereafter.

   • Biomarkers
   • Genetics
6. 40/100

   Validation of ELISA methods for quantification of total tau and phosporylated-tau181 in human cerebrospinal fluid with measurement in specimens from two Alzheimer's disease studies

   ✓ Peer-reviewed alzhub usefulness score 40 out of 100. Journal of Alzheimer's disease : JAD · 2011-01-01 · Biomarkers

   Tau measurements in cerebrospinal fluid (CSF) are gaining acceptance as aids to diagnosis of Alzheimer's disease (AD) and differentiation from other dementias.

   • Biomarkers
   • Clinical Trials
   • Treatments
7. 52/100

   Registration based cortical thickness measurement

   ✓ Peer-reviewed alzhub usefulness score 52 out of 100. NeuroImage · 2008-12-25 · Tau biomarkers

   Cortical thickness is an important biomarker for image-based studies of the brain.

   • Biomarkers
   • Brain Scans
8. 36/100

   Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma

   ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis · 2000-12-01 · Tau biomarkers

   The standardization and clinical validation of the measurement of beta-amyloid(1-42) (Abeta42) in cerebrospinal fluid (CSF), plasma and urine is described using a commercially available sandwich-type ELISA with 21F12 and 3D6 as monoclonal antibodies.

   • Biomarkers
   • Brain Biology

All topic tags with their study counts